drugset / Trial / NCT06281470
The Safety and Tolerability of WS016 in Healthy Chinese Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinic trial evaluates the safety and tolerability of single- and multiple- ascending doses of WS016 in healthy adult participants. There will be about 64 participants,48 active and 16 placebo.
Timeline
- Start
- 2023-02-13
- Primary completion
- 2023-06-15
- Completion
- 2023-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WS016 | Unknown | 6 g | Oral |
| Subject | WS016 | Unknown | 12 g | Oral |
| Subject | WS016 | Unknown | 24 g | Oral |
| Subject | WS016 | Unknown | 36 g | Oral |
| Subject | WS016 | Unknown | 48 g | Oral |
Indications
No indication recorded.